Equatorial Guinea vs Mali: Hepatitis B surface antigen (HBsAg) prevalence
Equatorial Guinea
2.0%
in 2024
Mali
1.8%
in 2024
Equatorial Guinea rank
12th
Mali rank
13th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Equatorial Guinea
- Mali
How they compare
Equatorial Guinea currently reports 2.0% against 1.8% in Mali, a difference of 0.2%.
That makes Equatorial Guinea's figure about 1.1 times Mali's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Equatorial Guinea ahead.
Equatorial Guinea ranks 12th and Mali ranks 13th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 2.1% | 0.2% | Equatorial Guinea |
| 2020s | 2.1% | 2.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Equatorial Guinea or Mali?
- Equatorial Guinea, at 2.0% against 1.8% in Mali as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Equatorial Guinea and Mali?
- 0.2%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Mali?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and Mali rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Equatorial Guinea ranks 12th and Mali ranks 13th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.